The molecular pharmacology departments of Organon have recently purchased the XE module of ActivityBase from IDBS following extensive collaboration and a piloting scheme.
Organon has used ActivityBase since 2002 for compound screening. The new module increases workflow by performing verification, analysis and visualisation within one environment, and reduced template maintenance.